ArticleJournal of affective disorders2026

SGLT2 inhibitors versus GLP-1 receptor agonists and risk of kidney replacement therapy and healthcare utilization in bipolar disorder with chronic kidney disease: An active-comparator, new-user cohort study.

Balwinder Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.